REG - Byotrol PLC - Directorate Changes

ByotrolAnnouncement

22/11/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221122:nRSV1156Ha&default-theme=true

RNS Number : 1156H  Byotrol PLC  22 November 2022

22 November, 2022

 

Byotrol plc

 

("Byotrol" or the "Company")

 

Directorate Changes

 

 

Byotrol plc, the developer of anti-microbial hygiene technologies, announces
the following long-planned board changes.

 

·    John Langlands, Non-Executive Chairman since February 2017, has
notified the Board of his wish to retire from business and to step-down as
Chairman and as a Director of Byotrol.  John originally only intended to
serve as Chairman of Byotrol for five years, but has remained slightly longer
to guide the Company through this year's AGM. John will initially remain as a
Non Executive Director to aid the leadership transition, but will then retire
as a Director on 31 January 2023, having completed 6 years of service.

·    David Traynor, Chief Executive Officer since October 2013 is moving
to Executive Chairman, with immediate effect. In addition to his
responsibilities as Chairman, David will now focus on securing and developing
intellectual property agreements and commercial alliances for the Company.

·    Vivan Pinto, currently Byotrol's Chief Growth Officer, and formerly
VP and Area MD at Johnson and Johnson Consumer Health, is being promoted to
Chief Executive Officer and joins the Board as an Executive Director with
immediate effect. He will now assume formal responsibility for the day-to-day
sales and operations of the Company, working closely with Chris Sedwell,
Executive Director and Chief Financial Officer.

The Board wishes to express formally its sincere thanks to John Langlands for
his guidance and advice to the Company over the last six years, during highly
volatile market conditions.

 

 

John Langlands, outgoing Non-Executive Chairman, commented:

 

"I have certainly enjoyed my time as Chairman of Byotrol, but with the
pandemic now subsiding and the Byotrol team and its technologies so much
improved, it is the right time for me to step-down. I will remain a supportive
shareholder and will continue to offer the team advice where I can."

 

David Traynor, incoming Executive Chairman, commented:

 

"We are very grateful to John for his excellent contribution to the Company
through some extraordinary times and wish him every happiness in his
retirement. We will certainly miss his calm, pragmatic and good-humoured
presence in the Company.

 

"I am looking forward to taking over as Chairman of the Company and handing
the CEO reins across to Vivan Pinto. Vivan has had a big impact on our
business so far and has an excellent track record of building healthy
businesses at all operational levels."

Vivan Pinto, incoming Chief Executive Officer, commented:

 

"Byotrol has built an exceptional base of technology platforms, the most
recent of which we launched last week at the London Vet Show.  I know we can
bring those technologies to more customers in more geographies and I am
looking forward to making it happen."

 

 

 Byotrol Plc
 David Traynor - Executive Chairman                                    +44 (0)1925 742 000

 Vivan Pinto - Chief Executive Officer
 Chris Sedwell - Chief Financial Officer

 finnCap Limited (Nominated Adviser and Broker)                        +44 (0)20 7220 0500
 Geoff Nash / George Dollemore - Corporate Finance
 Nigel Birks / Harriet Ward - ECM

 Flagstaff Strategic and Investor Communications                       +44 (0)20 7129 1474
 Tim Thompson/Andrea Seymour/Fergus Mellon                             byotrol@flagstaffcomms.com (mailto:byotrol@flagstaffcomms.com)

 

 

AIM Rules, Schedule 2(g) disclosures:

In accordance with Schedule 2(g) of the AIM Rules, Vivan Francis Pinto, aged
49, holds or has held, within the last five years, the following directorships
and partnerships:

 

 Current directorships/partnerships  Past directorships/partnerships
                                     Johnson and Johnson (Pty) Ltd

 

 

At the date of this announcement, Mr Pinto has an interest in 300,000 ordinary
shares representing 0.07% of the total voting rights of the Company and
3,076,923 Convertible Loan Notes, which if fully converted would represent an
additional 0.68% of the total voting rights of the Company.

 

There is no further information disclosable in respect of Vivan Pinto pursuant
to Schedule 2(g) of the AIM rules for companies.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABBBFTMTATBAT